Form 4: Labcorp Director Sampson Receives 773 Restricted Stock Units

Labcorp Holdings Inc. Director John H. Sampson was granted 773 Restricted Stock Units, aligning his interests with shareholders.

Summary

• John H. Sampson, a Director of Labcorp Holdings Inc. (LH), acquired 773 Restricted Stock Units (RSUs).
• Each RSU represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
• The RSUs were granted on February 10, 2026, and are scheduled to vest fully on February 10, 2027.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting standard compensation practices and increased insider alignment, without indicating any significant operational changes.

Positives

• Increased alignment of a director's interests with long-term shareholder value through equity ownership.
• The grant of Restricted Stock Units is a common form of executive and director compensation, indicating ongoing commitment to the company.

Negatives

• The grant of RSUs, while not immediate dilution, represents future potential dilution when they vest and convert to common stock.
• No direct cash investment by the director, as RSUs are typically granted at a $0 acquisition price.

Risks

• Future dilution of existing shareholders if the RSUs convert to common stock without corresponding value creation.
• The value of the RSUs is tied to the future stock price of Labcorp Holdings Inc., exposing the director to market risk.

Future Outlook

The 773 Restricted Stock Units granted to Director John H. Sampson are scheduled to vest fully on February 10, 2027, at which point they will convert into shares of Labcorp Holdings Inc. Common Stock.

Industry Context

StockSavvy.ai notes that the grant of Restricted Stock Units to a director is a standard practice in corporate compensation, aiming to align the interests of board members with long-term shareholder value. This type of insider transaction, especially when part of a 10b5-1 plan, is generally viewed as routine and not indicative of significant operational or strategic shifts.

Stakeholder Impact

• Shareholders: Potential for minor future dilution upon vesting, but also increased alignment of director's interests with long-term stock performance.

Next Steps

• The 773 Restricted Stock Units will vest fully on February 10, 2027.

Key Dates

Keywords

Labcorp Holdings Inc., LH, John H. Sampson, Restricted Stock Units, RSU, Insider Transaction, Form 4, Director Compensation, Equity Grant, 10b5-1 Plan